Clinical trial

Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis

NCT00304889 · Michael E. DeBakey VA Medical Center, U.S. Fed · Completed

Key facts

NCT number NCT00304889
Title Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis
Official title Vancomycin Vs. Nitazoxanide to Treat Clostridium Difficile Colitis That Has Failed Therapy With Metronidazole
Lead sponsor Michael E. DeBakey VA Medical Center, U.S. Fed
Collaborators Baylor College of Medicine
Status Completed
Study type Observational
Conditions Clostridium Enterocolitis, Pseudomembranous Colitis, Antibiotic-Associated Colitis
Enrollment 52
Start date Jan 1, 2006
Primary completion Jan 1, 2008
Completion Jan 1, 2008
First posted Mar 20, 2006
Last update posted Jun 3, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies